Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
1700652
Reference Type
Journal Article
Title
Pharmacodynamics of in vivo nitroglycerin tolerance in normal conscious rats: Effects of dose and dosing protocol
Author(s)
Wang, EQ; Balthasar, JP; Fung, HL
Year
2004
Is Peer Reviewed?
1
Journal
Pharmaceutical Research
ISSN:
0724-8741
EISSN:
1573-904X
Volume
21
Issue
1
Page Numbers
114-120
Language
English
PMID
14984265
DOI
10.1023/B:PHAM.0000012158.80991.7e
Web of Science Id
WOS:000188120800015
Abstract
Purpose. We examined the effects of dose and dosing protocol on the pharmacodynamics of in vivo nitroglycerin (NTG) tolerance in conscious rats. Mechanism-based pharmcokinetic/pharmacodynamic (PK/PD) models were tested for their ability to describe the observed data.
Methods. Rats were infused with 1, 3, or 10 mug/min of NTG or vehicle for 10 h. Peak mean arterial pressure (MAP) response to an hourly 30 mug i.v. NTG challenge dose (CD) was measured before, during, and at 12 and 24 h after infusion. In separate experiments, the MAP effects of repeated bolus doses of NTG were compared to those after a continuous infusion, both at a total dose of 510 mug NTG.
Results. NTG tolerance was indicated by a decrease in peak MAP response to the CD, relative to the preinfusion peak MAP response. Tolerance toward the MAP effects of bolus CD was observed within 1 h of 10 mug/min of NTG infusion (26.8 +/- 2.8% vs. 10.6 +/- 0.4% for 0 and 1 h, respectively, p < 0.001), and the rate and extent of tolerance development increased with the infusion dose. No apparent MAP tolerance was observed when NTG was given as multiple bolus doses whereas significant MAP tolerance was observed when this dose was infused continuously. PK/PD modeling indicated that a cofactor/enzyme depletion mechanism could adequately describe the composite data.
Conclusions. Our data showed that in vivo nitrate tolerance was dose- and dosing protocol-dependent. The pharmacodynamics of tolerance development are consistent with depletion of either critical enzymes or cofactors that are necessary to induce vasodilation.
Keywords
dosing protocol; mean arterial pressure; modeling; nitroglycerin tolerance; pharmacodynamics
Tags
•
Nitrate/Nitrite
Supplemental LitSearch Update 1600-2015
PubMed
WoS
New to project
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity